The $1.5m was a seeding order. If the distributor is able to market these to multiple hospitals/centres in different Chinese cities then I believe an order of 10x that would not be out of all possibility. We are talking about China after all.
The amount of ppl in China getting diagnosed with lung diseases is growing by the day, and the pollution in major population centres will be getting worse for a long time.
This plus FDA, plenty of upside.
I'm also curious to see ultralute impact and effect on earnings. I spoke with one of the ultralute scientists at the AGM - he reinforced how much of a revolutionary product this is and was hopeful that the International Atomic Energy Agency may help us sell the product, due to global Molybdenum shortages.
Exciting times ahead
CYC Price at posting:
98.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)